Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  EntreMed Inc    

SummaryNewsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Develops pharmaceutical drugs for treating cancer and inflammatory diseases

CASI Pharmaceuticals, Inc. is a biopharmaceutical company focused on the acquisition, development and commercialization of therapeutics addressing cancer and other unmet medical needs with commercial focus on the China market.

The Company operates through one business segment, which is the development of targeted therapeutics primarily for the treatment of cancer.

The company develops and commercializes the oncology drugs and drug candidates in China, Taiwan, Hong Kong and Macau.

The drugs are Captisol-Enabled, ZEVALIN and MARQIBO.

CASI Pharmaceuticals was founded in 1991 and is headquartered in Rockville, MD.
Managers
NameAgeSinceTitle
Ken Keyong Ren MD, PhD572012Chief Executive Officer & Director
Wei-Wu He PhD, MBA512012Executive Chairman
Cynthia Wong Hu462006COO, Secretary, Vice President & General Counsel
Sara B. Capitelli, CPA492011Chief Accounting Officer & Vice President-Finance
Rong Chen MD, PhD-2015Chief Medical Officer
Zuie Chin Huang, MBA502013Independent Director
Yue Alexander Wu PhD, MBA522013Independent Director
Franklin Cary Salisbury, Jr.602014Independent Director
Rajesh C. Shrotriya, MD722014Independent Director
Quan Zhou, PhD582016Director
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Share A 1 60,276,119 33,568,939 55.7% 79,545 0.1% 55.7%
Shareholders
NameEquities%
Spectrum Pharmaceuticals, Inc. 10,028,579 20.3%
He Xie Ai Qi Investment Management Beijing Co. Ltd. 8,498,765 17.2%
IDG Capital Partners Co., Ltd. 6,842,783 13.8%
Zhejiang Kanglaite Group Co. Ltd. 2,469,135 4.99%
Celgene Corp. 2,464,987 4.98%
Emerging Technology Partners LLC 2,312,677 4.68%
Wellington Shields Capital Management LLC 557,268 1.13%
Wellington Shields & Co. LLC 505,474 1.02%
Kleiner Perkins Caufield & Byers LLC 416,666 0.84%
The Vanguard Group, Inc. 366,642 0.74%
Sector
Healthcare
Pharmaceuticals & Medical Research
 Biotechnology & Medical Research
  Biotechnology & Medical Research
   Biotechnology & Medical Research - NEC
Advertisement
Sector Biotechnology & Medical Research - NEC
1st jan.Capitalization (M$)
ENTREMED INC84
INCYTE CORPORATION-1.14%20 197
QUINTILES IMS HOLDINGS..12.99%19 099
CELLTRION, INC.--.--%9 992
SEATTLE GENETICS, INC.48.48%9 433
LONZA GROUP AG8.34%9 288
ALKERMES PLC-26.59%8 855
QIAGEN NV1.12%6 702
UNITED THERAPEUTICS CO..-12.69%5 799
IONIS PHARMACEUTICALS ..-23.38%5 751
ICON PLC-1.71%4 235
BIO-TECHNE CORP20.28%4 039
INTREXON CORP1.13%3 615
ALNYLAM PHARMACEUTICAL..-55.59%3 588
CHARLES RIVER LABORATO..-7.94%3 503
ACADIA PHARMACEUTICALS..-20.76%3 421
PAREXEL INTERNATIONAL ..-13.77%3 336
PRA HEALTH SCIENCES IN..19.55%3 282
BB BIOTECH AG-9.24%3 016
GALAPAGOS-0.62%2 765
INC RESEARCH HOLDINGS ..5.55%2 657
Sector Biotechnology & Medical Research - NEC
EntreMed Inc : Connections
CASI Pharmaceuticals, Inc.
9620 Medical Center Drive
Suite 300
Rockville, MD 20850

Phone : +1.240.864.2600
Fax : +1.240.315.2437
Web : www.casipharmaceuticals.com
© 2016 People , Fundamentals and Ownership